refusal of approval

See: veto
References in periodicals archive ?
Lack of compliance with GCP in sponsoring or performing clinical studies will result in sanctions and refusal of approvals which will adversely affect the company's plans to launch a new drug product, device or diagnostic.
Lack of compliance with GCP in sponsoring or performing clinical studies will result in regulatory sanctions and refusal of approvals, which will adversely affect a company's plans to launch a new drug product, device, or diagnostic.